43
Participants
Start Date
May 15, 2019
Primary Completion Date
June 2, 2022
Study Completion Date
June 2, 2022
Apomorphine
Apomorphine (5 mg/ml), supplied as solution for infusion in a 10 ml glass ampoule Hourly flow rate adjusted during the whole duration of the study to obtain the best effect in each patient
Dopaminergic Agonist + Apomorphine
Apomorphine (5 mg/ml), supplied as solution for infusion in a 10 ml glass ampoule Hourly flow rate adjusted during the whole duration of the study to obtain the best effect in each patient and associated with dopaminergic agonists
CH Caremeau, Nîmes
Hôpital Gui de Chauliac, Montpellier
CHU de Rennes, Rennes
CHU de Reims- hôpital Maison Blanche, Reims
CHU La Pitié Salpêtrière, Paris
CHU Charles Nicolle, Rouen
Rennes University Hospital
OTHER